Furthermore, we have identified WT1, whose expression is induced by the oncogenic signaling triggered by BCR-ABL via the PI3K/AKT pathway [19], as a transcriptional repressor of ZNF224 in CML. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.